IS5497A - Bífenýlamidínafleiður - Google Patents

Bífenýlamidínafleiður

Info

Publication number: IS5497A
Authority: IS; Iceland
Prior art keywords: bífenýlamidínafleiður; chem; pharmaceutically acceptable; general formula; acceptable salt
Prior art date: 1997-11-20

Application number

IS5497A

Other languages

English (en)

Inventor

Takano Yasunobu

Nakada Tomohisa

Hara Takayuki

Sugiura Satoshi

Tsutsumi Takaharu

Takarada Reiko

Takazawa Yoshiharu

Original Assignee

Teijin Limited

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1997-11-20

Filing date

2000-05-15

Publication date

2000-05-15

2000-05-15 Application filed by Teijin Limited filed Critical Teijin Limited

2000-05-15 Publication of IS5497A publication Critical patent/IS5497A/is

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D207/08—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon radicals, substituted by hetero atoms, attached to ring carbon atoms
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C251/00—Compounds containing nitrogen atoms doubly-bound to a carbon skeleton
- C07C251/02—Compounds containing nitrogen atoms doubly-bound to a carbon skeleton containing imino groups
- C07C251/18—Compounds containing nitrogen atoms doubly-bound to a carbon skeleton containing imino groups having carbon atoms of imino groups bound to carbon atoms of rings other than six-membered aromatic rings
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C257/00—Compounds containing carboxyl groups, the doubly-bound oxygen atom of a carboxyl group being replaced by a doubly-bound nitrogen atom, this nitrogen atom not being further bound to an oxygen atom, e.g. imino-ethers, amidines
- C07C257/10—Compounds containing carboxyl groups, the doubly-bound oxygen atom of a carboxyl group being replaced by a doubly-bound nitrogen atom, this nitrogen atom not being further bound to an oxygen atom, e.g. imino-ethers, amidines with replacement of the other oxygen atom of the carboxyl group by nitrogen atoms, e.g. amidines
- C07C257/18—Compounds containing carboxyl groups, the doubly-bound oxygen atom of a carboxyl group being replaced by a doubly-bound nitrogen atom, this nitrogen atom not being further bound to an oxygen atom, e.g. imino-ethers, amidines with replacement of the other oxygen atom of the carboxyl group by nitrogen atoms, e.g. amidines having carbon atoms of amidino groups bound to carbon atoms of six-membered aromatic rings
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D207/08—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon radicals, substituted by hetero atoms, attached to ring carbon atoms
- C07D207/09—Radicals substituted by nitrogen atoms, not forming part of a nitro radical
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D207/10—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D207/16—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
- C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D211/20—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms
- C07D211/22—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms by oxygen atoms
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
- C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D211/26—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by nitrogen atoms
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
- C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D211/26—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by nitrogen atoms
- C07D211/28—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by nitrogen atoms to which a second hetero atom is attached
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D211/40—Oxygen atoms
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D211/60—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D211/62—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals attached in position 4
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
- C07C2601/14—The ring being saturated

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Health & Medical Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Life Sciences & Earth Sciences (AREA)
Diabetes (AREA)
Hematology (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Engineering & Computer Science (AREA)
Pharmacology & Pharmacy (AREA)
Bioinformatics & Cheminformatics (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

IS5497A 1997-11-20 2000-05-15 Bífenýlamidínafleiður IS5497A (is)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
JP31969897		1997-11-20
JP12749898		1998-05-11
PCT/JP1998/005209 WO1999026918A1 (en)	1997-11-20	1998-11-19	Biphenylamidine derivatives

Publications (1)

Publication Number	Publication Date
IS5497A true IS5497A (is)	2000-05-15

Family

ID=26463455

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
IS5497A IS5497A (is)	1997-11-20	2000-05-15	Bífenýlamidínafleiður

Country Status (28)

Country	Link
US (1)	US6706745B1 (is)
EP (1)	EP1043310B1 (is)
KR (1)	KR100581506B1 (is)
CN (1)	CN1150162C (is)
AT (1)	ATE268751T1 (is)
AU (1)	AU744567B2 (is)
BG (1)	BG63536B1 (is)
BR (1)	BR9814983A (is)
CA (1)	CA2310331A1 (is)
DE (1)	DE69824450T2 (is)
DK (1)	DK1043310T3 (is)
EE (1)	EE04564B1 (is)
ES (1)	ES2218866T3 (is)
HR (1)	HRP20000304B1 (is)
HU (1)	HUP0100085A3 (is)
ID (1)	ID24846A (is)
IL (1)	IL136100A (is)
IS (1)	IS5497A (is)
NO (1)	NO20002589L (is)
NZ (1)	NZ504407A (is)
PL (1)	PL340658A1 (is)
PT (1)	PT1043310E (is)
RU (1)	RU2197478C2 (is)
SK (1)	SK7612000A3 (is)
TR (1)	TR200001452T2 (is)
TW (1)	TW523504B (is)
UA (1)	UA52797C2 (is)
WO (1)	WO1999026918A1 (is)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
KR20010032175A (ko) *	1997-11-20	2001-04-16	야스이 쇼사꾸	비페닐아미딘 유도체
WO2000044380A1 (en) *	1999-01-28	2000-08-03	Teijin Limited	Release-regulating preparations
AU4614100A (en) *	1999-05-17	2000-12-05	Teijin Limited	Cyanobiphenyl derivatives
US20020065303A1 (en) *	2000-02-01	2002-05-30	Bing-Yan Zhu	Bivalent phenylene inhibitors of factor Xa
RU2273633C9 (ru) *	2000-10-04	2006-10-20	Киссеи Фармасьютикал Ко., Лтд.	Производные 5-амидино-2-гидроксибензолсульфонамида, содержащие их фармацевтические композиции и промежуточные продукты для их получения
US6316475B1 (en) *	2000-11-17	2001-11-13	Abbott Laboratories	Aminoalkoxybiphenylcarboxamides as histamine-3 receptor ligands and their therapeutic applications
JPWO2002059091A1 (ja) *	2001-01-26	2004-05-27	帝人株式会社	シアノフェニル安息香酸誘導体の製造法
CN1489575A (zh) *	2001-01-29	2004-04-14	��ʽ��	苯甲脒衍生物及其制备方法
WO2002060448A1 (fr) *	2001-01-30	2002-08-08	Teijin Limited	Composition medicinale
AR035425A1 (es) *	2001-01-30	2004-05-26	Teijin Ltd	Cristal de diclorhidrato del acido 3-(3-amidinofenil)-5-[({[1-(iminoetil)-4-piperidil]metil}amino)metil]benzoico y proceso para prepararlo
US20050014787A1 (en) *	2001-11-09	2005-01-20	Masahiko Uchida	5-amidino-2-hydroxybenzenesulfonamide derivatives medicinal compoistions containing the same medicinal use thereof and intermediates in the production thereof
WO2003048111A1 (fr)	2001-11-30	2003-06-12	Teijin Limited	Procede pour produire un compose d'acide 5-(3-cyanophenyl)-3-formylbenzoique
CA2507707C (en)	2002-12-03	2011-06-21	Axys Pharmaceuticals, Inc.	2-(2-hydroxybiphenyl-3-yl)-1h-benzoimidazole-5-carboxamidine derivatives as factor viia inhibitors
WO2006003881A1 (ja) *	2004-06-30	2006-01-12	Toyama Chemical Co., Ltd.	新規なアリールアミジン誘導体およびその塩ならびにそれらを含有する抗真菌剤
CA2619745A1 (en)	2005-08-18	2007-02-22	Teijin Pharma Limited	Tablet with multiple drug-containing sections
CN101291656B (zh)	2005-08-18	2012-11-07	帝人制药株式会社	具有准确的用量分割功能的制剂
PE20070698A1 (es)	2005-11-14	2007-08-17	Teijin Pharma Ltd	Comprimido de disgregacion rapida intraoral que contiene hidrocloruro de ambroxol
US10464896B2 (en)	2015-06-11	2019-11-05	Basilea Pharmaceutica International AG	Efflux-pump inhibitors and therapeutic uses thereof

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
FR2550192B1 (fr) *	1983-08-03	1986-04-04	Sanofi Sa	Nouveaux derives de la benzamidine a activite antimicrobienne, leur procede de preparation, leur utilisation en tant que medicaments desinfectants ou conservateurs
DE4102024A1 (de)	1991-01-24	1992-07-30	Thomae Gmbh Dr K	Biphenylderivate, diese verbindungen enthaltende arzneimittel und verfahren zu ihrer herstellung
EP0567967B1 (de) *	1992-04-28	1996-07-10	Dr. Karl Thomae GmbH	Tritiumarkierte Fibrinogen-Rezeptor-Antagonisten, deren Verwendung und Verfahren zur ihrer Herstellung
DE4219158A1 (de) *	1992-06-11	1993-12-16	Thomae Gmbh Dr K	Biphenylderivate, diese Verbindungen enthaltende Arzneimittel und Verfahren zu ihrer Herstellung
DE19546452A1 (de) *	1995-12-13	1997-06-19	Boehringer Ingelheim Kg	Neue Phenylamidinderivate, Verfahren zu ihrer Herstelung und ihre Verwendung als Arzneimittel
JPH101467A (ja) *	1996-06-13	1998-01-06	Banyu Pharmaceut Co Ltd	ビフェニルアミジン誘導体
DE19636689A1 (de) *	1996-09-10	1998-03-12	Boehringer Ingelheim Kg	Neue Benzamidinderivate
KR20010032175A (ko) *	1997-11-20	2001-04-16	야스이 쇼사꾸	비페닐아미딘 유도체

1998
- 1998-11-19 DK DK98954747T patent/DK1043310T3/da active
- 1998-11-19 ES ES98954747T patent/ES2218866T3/es not_active Expired - Lifetime
- 1998-11-19 AT AT98954747T patent/ATE268751T1/de not_active IP Right Cessation
- 1998-11-19 BR BR9814983-0A patent/BR9814983A/pt not_active Application Discontinuation
- 1998-11-19 ID IDW20000955A patent/ID24846A/id unknown
- 1998-11-19 NZ NZ504407A patent/NZ504407A/en unknown
- 1998-11-19 EP EP98954747A patent/EP1043310B1/en not_active Expired - Lifetime
- 1998-11-19 IL IL13610098A patent/IL136100A/xx not_active IP Right Cessation
- 1998-11-19 CN CNB988132206A patent/CN1150162C/zh not_active Expired - Fee Related
- 1998-11-19 HR HR20000304A patent/HRP20000304B1/xx not_active IP Right Cessation
- 1998-11-19 KR KR1020007005463A patent/KR100581506B1/ko not_active Expired - Fee Related
- 1998-11-19 US US09/554,799 patent/US6706745B1/en not_active Expired - Fee Related
- 1998-11-19 TW TW087119208A patent/TW523504B/zh not_active IP Right Cessation
- 1998-11-19 UA UA2000063535A patent/UA52797C2/uk unknown
- 1998-11-19 CA CA002310331A patent/CA2310331A1/en not_active Abandoned
- 1998-11-19 HU HU0100085A patent/HUP0100085A3/hu unknown
- 1998-11-19 AU AU11740/99A patent/AU744567B2/en not_active Ceased
- 1998-11-19 SK SK761-2000A patent/SK7612000A3/sk unknown
- 1998-11-19 DE DE69824450T patent/DE69824450T2/de not_active Expired - Fee Related
- 1998-11-19 TR TR2000/01452T patent/TR200001452T2/xx unknown
- 1998-11-19 EE EEP200000298A patent/EE04564B1/xx not_active IP Right Cessation
- 1998-11-19 WO PCT/JP1998/005209 patent/WO1999026918A1/ja not_active Ceased
- 1998-11-19 PT PT98954747T patent/PT1043310E/pt unknown
- 1998-11-19 RU RU2000115947/04A patent/RU2197478C2/ru not_active IP Right Cessation
- 1998-11-19 PL PL98340658A patent/PL340658A1/xx not_active Application Discontinuation
2000
- 2000-05-15 IS IS5497A patent/IS5497A/is unknown
- 2000-05-17 BG BG104447A patent/BG63536B1/bg unknown
- 2000-05-19 NO NO20002589A patent/NO20002589L/no unknown

Also Published As

Publication number	Publication date
EP1043310B1 (en)	2004-06-09
AU1174099A (en)	1999-06-15
PT1043310E (pt)	2004-10-29
US6706745B1 (en)	2004-03-16
CN1284059A (zh)	2001-02-14
NO20002589L (no)	2000-07-19
IL136100A (en)	2005-05-17
HRP20000304B1 (en)	2005-08-31
BR9814983A (pt)	2000-10-03
TW523504B (en)	2003-03-11
CN1150162C (zh)	2004-05-19
PL340658A1 (en)	2001-02-12
WO1999026918A1 (en)	1999-06-03
AU744567B2 (en)	2002-02-28
EE200000298A (et)	2001-08-15
HRP20000304A2 (en)	2002-02-28
RU2197478C2 (ru)	2003-01-27
UA52797C2 (uk)	2003-01-15
CA2310331A1 (en)	1999-06-03
EE04564B1 (et)	2005-12-15
SK7612000A3 (en)	2001-05-10
EP1043310A1 (en)	2000-10-11
ES2218866T3 (es)	2004-11-16
ID24846A (id)	2000-08-24
TR200001452T2 (tr)	2004-12-21
KR20010032259A (ko)	2001-04-16
BG63536B1 (bg)	2002-04-30
DK1043310T3 (da)	2004-10-25
ATE268751T1 (de)	2004-06-15
NZ504407A (en)	2002-02-01
BG104447A (en)	2001-01-31
DE69824450D1 (de)	2004-07-15
EP1043310A4 (en)	2001-03-21
HUP0100085A2 (hu)	2001-07-30
HUP0100085A3 (en)	2002-12-28
DE69824450T2 (de)	2005-09-29
NO20002589D0 (no)	2000-05-19
KR100581506B1 (ko)	2006-05-22
IL136100A0 (en)	2001-05-20

Publication	Publication Date	Title
NO20002589D0 (no)	2000-05-19	Bifenylamidinderivater
ATE260255T1 (de)	2004-03-15	5-oxo-pyrrolidine-2-carbonsäure- hydroxamidderivate
WO2001019828A3 (en)	2001-10-04	Kinase inhibitors as therapeutic agents
LU92113I2 (fr)	2013-02-12	Perampanel et ses dérivés pharmaceutiquement acceptables (FYCOMPA)
ATE306261T1 (de)	2005-10-15	Antithrombosemittel
DK0848004T3 (da)	2003-07-21	Pyrrolidinderivater med inhiberende aktivitet mod phospholipase A2
BR0014651A (pt)	2002-06-18	Inibidores de adesão de célula mediada por "alfa" l beta2
ATE272398T1 (de)	2004-08-15	Verwendung von ep4 rezeptorliganden zur behandlung von neuropathischen schmerz
NO20014925D0 (no)	2001-10-10	Farmasöytiske forbindelser
PT807630E (pt)	2003-08-29	Compostos heterociclicos
ATE198739T1 (de)	2001-02-15	2,3-diaminopropionsäurederivate
ATE271045T1 (de)	2004-07-15	Sauerstoffhaltige heterocyclische verbindungen
ATE278661T1 (de)	2004-10-15	Anthranilsäurederivate
DE60104697D1 (de)	2004-09-09	Sulfonamid-derivate
DE69623497D1 (de)	2002-10-10	1-methylcarbapenem-derivate
EP1152004A4 (en)	2002-01-23	PHOSPHONIC ACID DERIVATIVES HAVING CARBOXYPEPTIDASE B INHIBITOR ACTIVITY
MY129094A (en)	2007-03-30	Condensed polycyclic compounds
ES2185599T3 (es)	2003-05-01	Preparacion de intermediarios de la imidazodiacepina.
EP1466900A4 (en)	2005-07-20	DERIVATIVES OF VITAMIN D-DOUBLE SUBSTITUTION
PL342826A1 (en)	2001-07-02	Derivatives of cycloalkenes, their production and application